Features of carbohydrate metabolism and incretin secretion in patients with Cushing disease and acromegaly

Aim. This study aims to analyse the rhythm and levels of incretins and neuropeptides secretion in patients with Cushing disease (CD) and acromegaly, and thus specify the pathogenesis of carbohydrate metabolism disturbances. Matherials and methods. In this study, 42 patients (mean age, 37.5 years) wi...

Full description

Bibliographic Details
Main Authors: Lubov V. Matchekhina, Ekaterina A. Shestakova, Zhanna E. Belaya, Lyudmila I. Astafieva, Larisa V. Nikankina, Marina V. Shestakova
Format: Article
Language:English
Published: Endocrinology Research Centre 2017-10-01
Series:Сахарный диабет
Subjects:
Online Access:https://www.dia-endojournals.ru/jour/article/view/8672
_version_ 1797255165661675520
author Lubov V. Matchekhina
Ekaterina A. Shestakova
Zhanna E. Belaya
Lyudmila I. Astafieva
Larisa V. Nikankina
Marina V. Shestakova
author_facet Lubov V. Matchekhina
Ekaterina A. Shestakova
Zhanna E. Belaya
Lyudmila I. Astafieva
Larisa V. Nikankina
Marina V. Shestakova
author_sort Lubov V. Matchekhina
collection DOAJ
description Aim. This study aims to analyse the rhythm and levels of incretins and neuropeptides secretion in patients with Cushing disease (CD) and acromegaly, and thus specify the pathogenesis of carbohydrate metabolism disturbances. Matherials and methods. In this study, 42 patients (mean age, 37.5 years) with CD and acromegaly were enrolled. All patients were newly diagnosed with CD and acromegaly, and none had a history of previous drug therapy, radiotherapy or pituitary surgery. All patients underwent OGTT, during which glucose, glucagon, GLP-1, GLP-2, GIP and ghrelin were evaluated at 0, 30 and 120 min, respectively. Results. During OGTT, glucose levels were not significantly different between the groups. The relevance of pre-diabetes was higher in patients with CD. In these patients, while glucagon levels were substantially higher at all cut-off points than those in controls (р = 0.001), GIP secretion was slightly lower. The acromegaly group was characterised by an inverse rhythm of GIP secretion with no peak level at 30 min. In addition, GLP-1 levels were significantly higher in patients with CD (р = 0.047). Similarly, GLP-2 levels were also significantly higher in patients with CD than in those with acromegaly and controls (p = 0.001). Finally, ghrelin levels were significantly higher in patients with CD (р = 0.013) and acromegaly (р = 0.023). Conclusion. More pleiotropic actions of glucocorticoids can explain the higher relevance of carbohydrate metabolism disturbances in patients with CD. This can also be explained by higher levels of glucagon secretion, which do not depend on the type of carbohydrate metabolism disorder and are stimulated by a direct action of glucocorticoids on the glucagon receptor. GIP and GLP-1 secretion in patients with CD and acromegaly are characterised by the inverse rhythm with no peak levels, implying that these hormones do not play a crucial role in the development of carbohydrate disturbances in these patients. In contrast, GLP-2 and ghrelin seem to influence and potentially regulate glucose homeostasis in patients with CD and acromegaly.
first_indexed 2024-03-08T15:20:35Z
format Article
id doaj.art-b57c1f2833ba43a49646e293f39890b8
institution Directory Open Access Journal
issn 2072-0351
2072-0378
language English
last_indexed 2024-04-24T22:01:31Z
publishDate 2017-10-01
publisher Endocrinology Research Centre
record_format Article
series Сахарный диабет
spelling doaj.art-b57c1f2833ba43a49646e293f39890b82024-03-20T11:48:01ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782017-10-0120424925610.14341/DM87627864Features of carbohydrate metabolism and incretin secretion in patients with Cushing disease and acromegalyLubov V. Matchekhina0Ekaterina A. Shestakova1Zhanna E. Belaya2Lyudmila I. Astafieva3Larisa V. Nikankina4Marina V. Shestakova5<p>Endocrinology Research Centre</p><p>Endocrinology Research Centre</p><p>Endocrinology Research Centre</p><p>N.N.Burdenko National Scientific and practical Centre for Neurosurgery</p><p>Endocrinology Research Centre</p><p>Endocrinology Research Centre</p>Aim. This study aims to analyse the rhythm and levels of incretins and neuropeptides secretion in patients with Cushing disease (CD) and acromegaly, and thus specify the pathogenesis of carbohydrate metabolism disturbances. Matherials and methods. In this study, 42 patients (mean age, 37.5 years) with CD and acromegaly were enrolled. All patients were newly diagnosed with CD and acromegaly, and none had a history of previous drug therapy, radiotherapy or pituitary surgery. All patients underwent OGTT, during which glucose, glucagon, GLP-1, GLP-2, GIP and ghrelin were evaluated at 0, 30 and 120 min, respectively. Results. During OGTT, glucose levels were not significantly different between the groups. The relevance of pre-diabetes was higher in patients with CD. In these patients, while glucagon levels were substantially higher at all cut-off points than those in controls (р = 0.001), GIP secretion was slightly lower. The acromegaly group was characterised by an inverse rhythm of GIP secretion with no peak level at 30 min. In addition, GLP-1 levels were significantly higher in patients with CD (р = 0.047). Similarly, GLP-2 levels were also significantly higher in patients with CD than in those with acromegaly and controls (p = 0.001). Finally, ghrelin levels were significantly higher in patients with CD (р = 0.013) and acromegaly (р = 0.023). Conclusion. More pleiotropic actions of glucocorticoids can explain the higher relevance of carbohydrate metabolism disturbances in patients with CD. This can also be explained by higher levels of glucagon secretion, which do not depend on the type of carbohydrate metabolism disorder and are stimulated by a direct action of glucocorticoids on the glucagon receptor. GIP and GLP-1 secretion in patients with CD and acromegaly are characterised by the inverse rhythm with no peak levels, implying that these hormones do not play a crucial role in the development of carbohydrate disturbances in these patients. In contrast, GLP-2 and ghrelin seem to influence and potentially regulate glucose homeostasis in patients with CD and acromegaly.https://www.dia-endojournals.ru/jour/article/view/8672acromegalycushing diseasecarbohydrate metabolism disturbancesincretinsneuropeptides
spellingShingle Lubov V. Matchekhina
Ekaterina A. Shestakova
Zhanna E. Belaya
Lyudmila I. Astafieva
Larisa V. Nikankina
Marina V. Shestakova
Features of carbohydrate metabolism and incretin secretion in patients with Cushing disease and acromegaly
Сахарный диабет
acromegaly
cushing disease
carbohydrate metabolism disturbances
incretins
neuropeptides
title Features of carbohydrate metabolism and incretin secretion in patients with Cushing disease and acromegaly
title_full Features of carbohydrate metabolism and incretin secretion in patients with Cushing disease and acromegaly
title_fullStr Features of carbohydrate metabolism and incretin secretion in patients with Cushing disease and acromegaly
title_full_unstemmed Features of carbohydrate metabolism and incretin secretion in patients with Cushing disease and acromegaly
title_short Features of carbohydrate metabolism and incretin secretion in patients with Cushing disease and acromegaly
title_sort features of carbohydrate metabolism and incretin secretion in patients with cushing disease and acromegaly
topic acromegaly
cushing disease
carbohydrate metabolism disturbances
incretins
neuropeptides
url https://www.dia-endojournals.ru/jour/article/view/8672
work_keys_str_mv AT lubovvmatchekhina featuresofcarbohydratemetabolismandincretinsecretioninpatientswithcushingdiseaseandacromegaly
AT ekaterinaashestakova featuresofcarbohydratemetabolismandincretinsecretioninpatientswithcushingdiseaseandacromegaly
AT zhannaebelaya featuresofcarbohydratemetabolismandincretinsecretioninpatientswithcushingdiseaseandacromegaly
AT lyudmilaiastafieva featuresofcarbohydratemetabolismandincretinsecretioninpatientswithcushingdiseaseandacromegaly
AT larisavnikankina featuresofcarbohydratemetabolismandincretinsecretioninpatientswithcushingdiseaseandacromegaly
AT marinavshestakova featuresofcarbohydratemetabolismandincretinsecretioninpatientswithcushingdiseaseandacromegaly